Safer Cycling In Older Age (SiFAr)

December 5, 2022 updated by: Robert Kob, University of Erlangen-Nürnberg Medical School

"Safer Cycling In Older Age" - a Multi-component Exercise Intervention in Community-dwelling, Older Adults.

The aim of the SiFAr-project is to increase safe cycling in community-dwelling older adults (age 65 years and older) with a structured, multi-component exercise cycling training. The progressive exercise program encompasses training of motor competence and cognitive functions. The ability to cycle safely will be tested prior and after the training period using a cycling course, which consists of variant tasks requiring motor and cognitive skills.

Study Overview

Detailed Description

Cycling is a form of physical activity that is positively associated with health and functional benefits. In Germany, the use of bicycles, especially of those with motorized assistance (e-bikes), is steadily increasing among older adults. Despite the benefits mentioned, cycling also poses potential health risks. For instance, there is a significant association between increased bicycle use and bicycle crashes. This relationship is particularly evident in older adults with a higher prevalence of bicycle crashes leading to minor and serious injuries. This might be explained by the age-related decline of physical and cognitive function, which may essentially affect (reduce) the ability to cycle safely. In order to prevent crashes and falls from bicycles, targeted training of the required skills for safe cycling could be effective. However, there is a lack of scientifically evaluated bicycle-training concepts that have been developed specifically for older adults.

By developing and providing a structured and progressive multi-component exercise program related to cycling for older adults, the SiFAr-project will address the improvement of bicycle-related basic motor competence (e.g. balance, strength, ability to react, cycling skills and techniques) and the reduction of stress and fall-related psychological concerns.

The ability to ride a bike safely will be measured in both arms before and after the training period by completing various tasks in a cycling course.

The aim of the program is that the participation in the three-month exercise intervention program will lead to a reduction of failures in the bicycle course. As comparative values, the number of faults in the bicycle course before the training period and the number of faults in the control group will be used. Furthermore, a substudy aim to investigate stress biomarkers targeting inflammatory and stress associated physiological parameters during cycling. The activity of stress systems will be determined by measuring stress hormones like cortisol and inflammatory responses in the body by measuring C-reactive protein. To analyse biomarkers, saliva, hair and blood specimen will be collected.

Study Type

Interventional

Enrollment (Actual)

127

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bavaria
      • Nürnberg, Bavaria, Germany, 90408
        • Institute for Biomedicine of Aging

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 100 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • living in the area Nürnberg-Fürth-Erlangen, Bavaria, Germany
  • Ability to come to training locations on their own bicycle, having a suitable helmet
  • participant is either 1) a beginner with the e-bike or has 2) self-reported insecurity or is 3) a re-entrant in cycling

Exclusion Criteria:

  • long-term, experienced cyclists without subjectively reported limitations or worries when cycling.
  • diseases that contradict safe participation in the intervention (e.g. myocardial infarction within the last 6 months, unstable angina pectoris, cerebrovascular event, serious cancer diagnosis, serious neurological diseases like Parkinson, dementia; and other serious new diagnosis)
  • other factor that prevent regular and safe participation in the intervention (e.g. prolonged holidays during the training period, alcoholism)
  • severe visual impairments that cannot be sufficiently compensated by a visual aid

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: IG
Intervention Group
Structured and progressive multicomponent exercise program with and without bikes. Training period will last over 3 months with 8 sessions à 60 minutes. Training sessions will address motor competence (balance, strength, cycling skills and techniques) and cognitive skills required during cycling. Furthermore, fall-related psychological concerns will be addressed.
Active Comparator: aCG
Control Group
HRP include 3 presentations on healthy aging (one per month) with a duration of 60 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of faults in the cycling course
Time Frame: changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months
The cycling competence will be tested in a standardized cycling course, including the following tasks: slalom, slow cycling within a marked lane, dismounting into a marked zone, getting on the bike, cycling through a narrow alley, turning to the off-side, braking with pinpoint accuracy. Mean change of number of faults in the cycling course will be tested between pre- and postintervention.
changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Physical Performance Battery (SPPB)
Time Frame: changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months
mean change in sumscore (0-12 points)
changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months
Fear of Falling (Short FES-I)
Time Frame: changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months
mean change in sumscore (7-28 points)
changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months
Cortisol
Time Frame: changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months
change in concentration in nmol/L by high-sensitive Enzyme-linked Immunosorbent Assay (ELISA)
changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months
Alpha-amylase
Time Frame: changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months
change in concentration in enzyme units U/mL by Enzyme kinetic Assay
changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months
C-reactive protein (CRP)
Time Frame: changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months
change in concentration in mg/L by high-sensitive Enzyme-linked Immunosorbent Assay (ELISA)
changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months
EuroQol (EQ-5D)
Time Frame: changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months
change in sumscore and change in mean value of Visual-Analogue-Scale (VAS, 0-100)
changes over a period of 3 months and after a follow-up period of 6-9 and in some cases 18-21 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Robert Kob, PhD, Institute for Biomedicine of Aging

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2020

Primary Completion (Actual)

November 1, 2022

Study Completion (Actual)

December 5, 2022

Study Registration Dates

First Submitted

April 14, 2020

First Submitted That Met QC Criteria

April 22, 2020

First Posted (Actual)

April 27, 2020

Study Record Updates

Last Update Posted (Estimate)

December 7, 2022

Last Update Submitted That Met QC Criteria

December 5, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Older Adults

Clinical Trials on MEPC - Multi-component exercise program related to cycling

3
Subscribe